[1]
D. Tupe, K. Bhave, and P. Pandit, “Cost analysis of drugs used in management of heart failure with reduced ejection fraction and marketed in India”, Int J Basic Clin Pharmacol, vol. 13, no. 5, pp. 612–618, Aug. 2024.